Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Roche has signed a licensing agreement, worth up to $2.85 billion ($1.15 billion upfront), with Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company, to provide Roche with exclusive commercial rights outside the US to...

The US Senate has confirmed Dr. Stephen Hahn of MD Anderson Cancer Center to serve as the next Commissioner of the US Food and Drug Administration. The Senate confirmed Dr. Hahn on December 12, 2019 with a vote of 72 in favor to 17 against. Dr....

A roundup of developments and latest news from Germany (AstraZeneca, Cheplapharm), India (Sun Pharmaceuticals), United States (Amneal, Eli Lilly and Company, Sanofi). Germany AstraZeneca Completes Agreement with Cheplapharm for...

The US House of Representatives has passed a proposed drug-pricing plan (H.R.3, Elijah E. Cummings Lower Drug Costs Now Act). The bill, which was first introduced in the House in September 2019, would establish a fair price negotiation program,...

Roche has completed its $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company. The completion follows the receipt of regulatory approval from all government authorities, including the US Federal Trade Commission,...

A roundup of developments and latest news from India (Aurobindo, Biocon), Japan (Kyowa Kirin), Singapore and South Korea (Ministry of Food and Drug Safety), United States (AstraZeneca, Recro Pharma, Horizon Pharma) India FDA Approves Biocon’s...